NYSE:KDMN
Delisted
Kadmon Holdings LLC Stock News
$9.50
+0 (+0%)
At Close: Aug 17, 2022
Kadmon Announces Update on pre-NDA Meeting with FDA and Provides Business Update
08:15pm, Friday, 13'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 13, 2020 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that the Company held its pre-New Drug Application (NDA) meeting as scheduled with the U.S. Food and Dru
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
09:36pm, Wednesday, 11'th Mar 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has appointed Tasos Konidaris as Senior Vice President, Chief Financial Officer, effective March 12, 2020. Mr.
Here's Why We're Not Too Worried About Kadmon Holdings's (NYSE:KDMN) Cash Burn Situation
05:57pm, Monday, 09'th Mar 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysts Are Bullish on These Healthcare Stocks: Kadmon Holdings (KDMN), Outlook Therapeutics (OTLK)
11:09am, Monday, 09'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kadmon Holdings (KDMN), Outlook Therapeutics (OTLK) and
Analysts Are Bullish on These Healthcare Stocks: Kadmon Holdings (KDMN), Outlook Therapeutics (OTLK)
11:09am, Monday, 09'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kadmon Holdings
Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year 2019 Financial Results
09:14pm, Thursday, 05'th Mar 2020
NEW YORK, March 05, 2020 -- Kadmon Holdings, Inc. (NYSE: KDMN) today provided a business update and reported financial and operational results for the fourth quarter and full.
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Esperion (ESPR)
11:15pm, Thursday, 27'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allogene Therapeutics (ALLO) and Esperion (ESPR) with
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (NASDAQ: ALLO) and Esperion (NASDAQ: ESPR)
11:15pm, Thursday, 27'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allogene Therapeutics
Iovance Biotherapeutics (IOVA) Received its Third Buy in a Row
11:25am, Wednesday, 26'th Feb 2020
After Piper Sandler and Cowen & Co. gave Iovance Biotherapeutics (NASDAQ: IOVA) a Buy rating last month, the company received another Buy, this time
Iovance Biotherapeutics (IOVA) Received its Third Buy in a Row
11:25am, Wednesday, 26'th Feb 2020
After Piper Sandler and Cowen & Co. gave Iovance Biotherapeutics (NASDAQ: IOVA) a Buy rating last month, the company received
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD
05:29pm, Sunday, 23'rd Feb 2020
Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD Pre-NDA Meeting with FDA Planned for March 2020; Topline Results of Primary Analysis to be Announced in Q2 202
Tracking Dan Loeb's Third Point Portfolio - Q4 2019 Update
03:05am, Tuesday, 18'th Feb 2020
Dan Loeb's 13F portfolio value increased from $8.42B to $8.70B this quarter. The number of positions decreased from 40 to 37. Third Point added IAA, Inc. while
3 Healthcare Stocks With Important Catalysts in Q1
02:33pm, Wednesday, 22'nd Jan 2020
Blink, and you might just miss it. We are referring to the colossal gains that can be achieved by a select group of stocks in almost no time at all, namely those inhabiting the healthcare sector. But
6 Cheap Stocks to Buy Under $7
03:22pm, Wednesday, 15'th Jan 2020
No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.